Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01719523 · ClinicalTrials.gov registry record · Phase 1
Open-Trial of EPI-743 for Adults With Tourette Syndrome
A Phase 1 study of Tourette Syndrome, sponsored by Yale University.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT01719523: Completed Phase 1 study of Tourette Syndrome, sponsored by Yale University.
NCT01719523 is a Phase 1 study of Tourette Syndrome that has completed, run by Yale University. The registered enrollment target is 10 participants, below the 86-participant average among 33 other Tourette Syndrome trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01719523, a Phase 1 study of Tourette Syndrome, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine the effects of EPI-743 on tic severity in adults with Tourette syndrome.
Conditions Studied
Interventions
- DRUG EPI-743
Study Locations (1)
Connecticut
- Yale Child Study Center - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2012-10 |
| Est. Completion | 2013-10 |
| Phase | Phase 1 |
What the finished NCT01719523 record still lists
NCT01719523 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 86-participant average among 33 other Tourette Syndrome trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Tourette Syndrome appearing as the primary indexed condition, and to 1 intervention - of which EPI-743 is the first listed.
NCT01719523 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT01719523 about?
NCT01719523 is a clinical study titled "Open-Trial of EPI-743 for Adults With Tourette Syndrome". The purpose of this study is to examine the effects of EPI-743 on tic severity in adults with Tourette syndrome.
What is the current status of trial NCT01719523?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2012-10. Estimated completion is 2013-10.
What conditions does trial NCT01719523 study?
This clinical trial studies the following conditions: Tourette Syndrome.
What interventions are being tested in trial NCT01719523?
The interventions under investigation include: EPI-743 (DRUG).
Who is sponsoring clinical trial NCT01719523?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01719523 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tourette Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01719523's enrollment target sits among peer trials
10 32nd of 33 higher than 2 of 33 other Tourette Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tourette Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Developing Cognitive Training for Tourette Syndrome
COMPLETED · Phase 1
-
Sensorimotor and Psychosocial Trajectories in Adolescents With Tic Disorder
RECRUITING
-
Remote Delivery of a Mindfulness-based Intervention for Tics
RECRUITING · NA
-
Sensory Symptoms in Tourette Syndrome
RECRUITING
-
Multimodal Profiling of Response to Pediatric Comprehensive Behavioral Intervention for Tics
RECRUITING · Phase 2
-
Trajectories of Change in Tourette Syndrome
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia